IR
Superintel
OverviewMarketsWatchlist
© 2026 IR SuperintelMethodologyContact

Sarissa Capital Management LP

Q1 2018 Holdings

Filed 2018-05-15 | 11 holdings | $113.7M | 13F-HR | View on SEC ↗ · Holdings Table ↗

Sign in to see sub-manager breakdown

IssuerClassCUSIPValue ↓Shares% Portfolio
Biogen Inc(BIIB)COM09062X103$113.3M413,85899.6%
Abbvie Inc(ABBV)COM00287Y109$94.0K1,0000.1%
Medicines CoCOM584688105$63.3K1,922,0000.1%
Innoviva Inc(INVA)COM45781M101$61.0K3,660,7050.1%
Allergan PLCSHSG0177J108$57.9K344,0000.1%
Ironwood Pharmaceuticals Inc(IRWD)COM CL A46333X108$52.0K3,367,1000.0%
Shire PLCSPONSORED ADR82481R106$39.4K264,0000.0%
Intercept Pharmaceuticals Inc(ICPTUSD)COM45845P108$39.1K635,3000.0%
Novelion Therapeutics IncCOM NEW67001K202$3.6K1,025,0000.0%
Achillion Pharmaceuticals Inc(ACHNEUR)COM00448Q201$1.9K500,0000.0%
Apricus Biosciences IncCOM NEW03832V307$5871,447,9060.0%